Rachel K. King - 31 Dec 2022 Form 5 Insider Report for GLYCOMIMETICS INC (GLYC)

Role
Director
Signature
/s/ Brian F. Leaf, attorney-in-fact
Issuer symbol
GLYC
Transactions as of
31 Dec 2022
Net transactions value
$0
Form type
5
Filing time
06 Feb 2023, 15:13:14 UTC
Previous filing
21 Jun 2022
Next filing
02 Apr 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GLYC Common Stock Will/Inheritance $0 +11,641 +2.4% $0.000000 500,955 15 Feb 2022 Direct F1, F2
transaction GLYC Common Stock Will/Inheritance $0 +7,500 $0.000000 7,500 02 Aug 2022 By RBK LLC F3
holding GLYC Common Stock 92,401 31 Dec 2022 By trusts F4
holding GLYC Common Stock 45,741 31 Dec 2022 By spouse
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 48,125 shares underlying restricted stock units held as of the date of this report. Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer.
F2 This total also includes 37,000 shares previously held by The Rachel K. King 2016 GRAT that were transferred to the reporting person on February 25, 2021 and are now owned directly by the reporting person.
F3 The reporting person is co-manager of this entity. She disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein.
F4 These shares are held by family trusts, for which Ms. King serves as trustee, as follows: 1,741 shares are held by The Connor A. King 1988 Trust, 1,741 shares are held by The Langley C. King 1990 Trust, 8,796 shares are held by the 1995 Connor A. King Trust, 8,796 shares are held by the 1995 Langley C. King Trust, 23,301 shares are held by The Connor King 2013 GRAT, 23,301 shares are held by The Langley C. King 2013 GRAT and 24,725 shares are held by The Rachel K. King 2016 GRAT. The number of shares held by The Rachel K. King 2016 GRAT excludes the 37,000 shares transferred to the reporting person as described in footnote 2.